 Visit the TF Network Sites · Institutional Investor Center · Individual Investor Center |
| Download Plug-In |
| Real
Player 8 Basic Windows Media Player |
| Other Conference Calls |
| Other May 6 Calls Today's Calls |
| Call Details | |||
| ATRICURE INC Earnings Conference Call (Q1 2008) Tue, May 6, 2008, 10:00 am Eastern
| |||
| About ATRICURE INC (NasdaqGM:ATRC) | |||
| AtriCure, Inc., a medical device company, engages in the development, manufacture, and sale of cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac tissue. The company provides AtriCure Isolator, which consists of an ablation sensing unit, a compact power generator that delivers bipolar radio-frequency energy; and AtriCure switch box, a compact switch box, which provides the technology needed for the dual pulsing electrodes, and ability to connect and toggle between multiple devices, including clamps and multifunctional pen. It also offers Isolator Bipolar Radio-Frequency Ablation Clamps for open-heart procedures and minimally invasive procedures; and Isolator Synergy that provides full thickness lesions in thicker and more diseased tissues. In addition, the company provides multifunctional bipolar pen, which enables surgeons to toggle back and forth between temporary pacing, sensing, stimulation, and ablation. Further, it offers Lumitip dissector to separate tissues to provide access to key anatomical structures that are targeted for ablation during general, thoracic, and other surgical procedures; AtriCure Left Atrial Appendage Exclusion System that is designed to exclude the left atrial appendage; and Frigitronics CCS-200 product line for cardiac cryoablation. The company sells its products to hospitals and medical clinics primarily through its direct sales force in the United States, as well as through distributors in Asia, Europe, South America, and Canada. AtriCure is headquartered in West Chester, Ohio. | |||
More Info: | |||
